Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1974-02-04
1976-12-21
Gotts, Lewis
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260455A, A61K 3127, C07C15508
Patent
active
039989640
ABSTRACT:
.alpha.-Amino-.beta.-(N-benzylthiocarbamoylthio)propionic acid provides strong anti-bacterial and anti-mycotic action coupled with excellent stability and tolerability when administered orally in mustard oil therapy.
REFERENCES:
patent: 2325720 (1943-08-01), Vrbschat et al.
patent: 2621143 (1952-12-01), Goodhue et al.
patent: 2650876 (1953-09-01), Stewart
patent: 2885433 (1959-05-01), Hagemann et al.
patent: 3089887 (1963-05-01), Metivier
patent: 3133112 (1964-05-01), Shive et al.
patent: 3539612 (1970-11-01), Tweit
Plijgers et al., "Syn. and Antifungal Activity etc.," (1967), Index Chemicas 33, No. 114, 196 (1969).
Smith et al., "Biol--Activities of Some Amino Acid etc.," (1962), Tex. Rpt. Biol. Med. Bd. 21, pp. 296-301, (1963).
Brusewitz Gerhard
Madaus Rolf
Dr. Madaus & Co.
Gotts Lewis
Phillips D. R.
LandOfFree
.alpha.-Amino-.beta.-(N-benzylthiocarbamoylthio) propionic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with .alpha.-Amino-.beta.-(N-benzylthiocarbamoylthio) propionic acid , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and .alpha.-Amino-.beta.-(N-benzylthiocarbamoylthio) propionic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1839498